An automated pheochromocytoma and paraganglioma lesion segmentation AI-model at whole-body 68Ga- DOTATATE PET/CT

Fahmida Haque,Jorge A. Carrasquillo,Evrim B. Turkbey,Esther Mena,Liza Lindenberg,Philip C. Eclarinal,Naris Nilubol,Peter L. Choyke,Charalampos S. Floudas,Frank I. Lin,Baris Turkbey,Stephanie A. Harmon
DOI: https://doi.org/10.1186/s13550-024-01168-5
IF: 3.434
2024-11-07
EJNMMI Research
Abstract:Somatostatin receptor (SSR) targeting radiotracer 68 Ga-DOTATATE is used for Positron Emission Tomography (PET)/Computed Tomography (CT) imaging to assess patients with Pheochromocytoma and paraganglioma (PPGL), rare types of Neuroendocrine tumor (NET) which can metastasize thereby becoming difficult to quantify. The goal of this study is to develop an artificial intelligence (AI) model for automated lesion segmentation on whole-body 3D DOTATATE-PET/CT and to automate the tumor burden calculation. 132 68 Ga-DOTATATE PET/CT scans from 38 patients with metastatic and inoperable PPGL, were split into 70, and 62 scans, from 20, and 18 patients for training, and test sets, respectively. The training set was further divided into patient-stratified 5 folds for cross-validation. 3D-full resolution nnUNet configuration was trained with 5-fold cross-validation. The model's detection performance was evaluated at both scan and lesion levels for the PPGL test set and two other clinical cohorts with NET ( n = 9) and olfactory neuroblastoma (ONB, n = 5). Additionally, quantitative statistical analysis of PET parameters including SUVmax, total lesion uptake (TLU), and total tumor volume (TTV), was conducted.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?